Heron Therapeutics, Inc (HRTX) Covered Calls

Heron Therapeutics Inc is a biotechnology company, developing products to address unmet medical needs. Its proprietary Biochronomer polymer-based drug delivery platform is designed to improve the therapeutic profile of injectable pharmaceuticals.

You can sell covered calls on Heron Therapeutics, Inc to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for HRTX (prices last updated Fri 4:16 PM ET):

Heron Therapeutics, Inc (HRTX) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
18.45 -0.75 18.41 18.99 514K -9.0 1.5B
Covered Calls For Heron Therapeutics, Inc (HRTX)
Expiration Strike Call Bid Net Debit Return
If Flat
Return If Flat
Aug 16 18 1.25 17.74 1.5% 18.9%
Sep 20 18 1.55 17.44 3.2% 18.3%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial

Extended Business Description

Heron Therapeutics, Inc. is a pharmaceutical company. It designs and commercializes of polymer technologies for pharmaceutical and other applications. The company develops products using its proprietary Biochronomer polymer based drug delivery technology. Its primary focus is on its product APF530, for the prevention of chemotherapy induced nausea and vomiting. The company has additional clinical and preclinical-stage programs in the area of pain management, all of which utilize its bioerodible, injectable and implantable delivery systems. Its Biochronomer technology is applicable to a range of therapeutics areas, including prevention of nausea and vomiting, pain management, control of inflammation and treatment of ophthalmic diseases. The company was founded in February 1983 and is headquartered in Redwood City, CA